-
Diagnostics World | A new web-based platform aims to standardize the care of rare disease patients in a wide range of settings and accelerate their diagnostic journey. The Rare Disease Clinical Activity Protocols (RareCAP) is effectively a collection of the latest research-based information and guidance about some of the more than 7,000 conditions affecting a small number of people.
Jul 23, 2024
-
Diagnostics World | Most of the time, sarcoidosis appears in the lungs and lymph nodes, but the heart is impacted in a smaller number of patients. Known as cardiac sarcoidosis (CS), this rare condition can lead to serious complications like arrhythmia or heart failure. Recently, Diagnostics World covered efforts to improve diagnostic and treatment options for sarcoidosis.
Jul 18, 2024
-
Diagnostics World | A recent analysis of interventional clinical trials by the Tufts Center for the Study of Drug Development (CSDD) has found that use of digital endpoints has been growing rapidly since 2015 with drug developers now initiating an average of about 35 such studies each year. News of the uptick isn’t entirely surprising, given mounting evidence that the approach can improve operational performance and ease patient burdens in clinical trials and in clinical practice, while [potentially] yielding financial net benefits to developers.
Jul 16, 2024
-
Diagnostics World | For more than 150 years now, medical scientists have been hunching over microscopes turning human tissue samples into crisp colored images that help pathologists diagnose diseases. Histology, as the field is known, has made an art of the complex business of creating high-quality microscope slides—and until recently done it in precisely the same way with consistently good results.
Jul 11, 2024
-
Diagnostics World | Machine learning models can be superior to radiologists when it comes to processing complex images and putting a predictive label on them, particularly at scale. The problems currently being studied in biomedicine with machine learning, such as identifying the subtype of cancer a patient has, are ones that have been largely ignored for a long time.
Jul 10, 2024
-
Diagnostics World | Proscia and Nucleai are partnering to integrate Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and make them available as part of Proscia’s AI-enabled pathology portfolio to better inform patient care.
Jul 9, 2024
-
Diagnostics World | Over 3.4 million people in the US and 65 million people worldwide are affected by epilepsy. To ensure that patients are getting the treatment they need, early detection is critical. Researchers at the University of Southern California have developed an AI system called NeuroGNN that can identify epilepsy by analyzing brain interactions with greater accuracy and efficiency.
Jul 1, 2024
-
Diagnostics World | Foresite Capital launches fund for three main areas: precision therapeutics, life science infrastructure, and healthcare delivery; Santa Ana Bio employs proteomic, transcriptomic, and genomic approaches to precisely characterize disease-specific subpopulations and identify targets only on disease-causing cell types leaving healthy cells unaffected; more.
Jun 27, 2024
-
Diagnostics World | PacBio, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation; PathAI unveiled two novel AI products, PathExplore Immuno-Oncology Profiling (IOP) and IHC Explore1; , Thermo Fisher Scientific has introduced One Lambda HLA PRO, an automated, modular pipetting system that offers versatility by accommodating different workflows on a single instrument, allowing laboratories to automate multiple human leukocyte antigen (HLA) and antibody testing technologies cost-effectively; more.
Jun 26, 2024
-
Diagnostics World | GRAIL, previously an Illumina company, began regular trading on Nasdaq today under the ticker symbol "GRAL." Illumina continues to trade on Nasdaq under the ticker symbol "ILMN."
Jun 25, 2024
-
Diagnostics World | Researchers at the Karolinska Institute in Stockholm, Sweden, have developed a new device for detecting malignant melanoma. Melanoma affects about one million people every year across the world, and over the past two decades, cases of melanoma have significantly increased due to higher rates of exposure to ultraviolet radiation and climate change.
Jun 21, 2024
-
Diagnostics World | Researchers in Israel who pioneered the discipline of “mechanomics” are now using the concept to fill the chasm between the expanding volume of ‘omics data and its translation into real-world clinical scenarios. Their aim is to help physicians predict the aggressiveness of cancer and a tumor’s potential resistance to treatment and, ultimately, improve patient outcomes.
Jun 18, 2024
-
Diagnostics World | Until recently, all the available therapeutic options for treating Alzheimer’s disease were designed to reduce symptoms rather than address causes of the disease. But with two beta-amyloid antibodies now approved by the U.S. Food and Drug Administration, and tau-targeting agents in clinical trials, hopes are rising that Alzheimer’s progression can be delayed if not stopped.
Jun 12, 2024
-
Diagnostics World | Sarcoidosis is difficult to diagnose for a variety of reasons. For one, it is not limited to a single area or part of the body. Although the vast majority of people living with sarcoidosis have it in their lungs, it can also appear in the eyes, the skin, brain, heart, spinal cord, liver, kidney, and even in the bones.
Jun 11, 2024
-
Diagnostics World | A potentially game-changing diagnostic assay is under development that can quickly and accurately identify who is and isn’t having a large vessel occlusion (LVO), a devastating subset of ischemic stroke that occurs when a major artery in the brain is blocked.
Jun 6, 2024
-
Diagnostics World News | Late today, Illumina announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is anticipated to spin off from Illumina on June 24, 2024, and has applied to list on Nasdaq as "GRAL."
Jun 3, 2024
-
Diagnostics World | After decades of false starts, digital pathology adoption is finally happening. Pathologists in these labs don’t have glass slides anywhere in their offices and have completely adapted their workflow and mindset to a digital world. They experience ‘faster than glass’ workflow advantages and tangible benefits associated with AI tools, but also have learned important lessons along the path to adoption.
May 31, 2024
-
Diagnostics World | Quest Diagnostics and PathAI announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations; Ambry Genetics and PacBio were selected to support the Pediatric Mendelian Genomics Research Center (MGRC) program; Foundation Medicine launches FoundationOne RNA; more.
May 29, 2024
-
Diagnostics World | Karius plans extend its reach beyond the 400 U.S. hospitals currently using the Karius Test, an infectious disease diagnostic test that utilizes genomic analysis and artificial intelligence to detect over 1,000 pathogens from a single blood sample; PinkDx launches to pursue its vision of identifying unmet medical needs that are unique to women; En Carta develops a point-of-care diagnostic for Lyme disease; more.
May 28, 2024
-
Diagnostics World | Using an artificial intelligence (AI) model that was trained on millions of variants from identified genetic disorders and incorporates the complex decision-making process of human molecular scientists, investigators at Baylor College of Medicine are on track to automate the diagnosis of an enormous number of undiagnosed conditions.
May 23, 2024